+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Search in Pharmaceuticals returned 45,003 results.

Strategy At Novartis: Culture Change As The 'How' Behind The 'What' - Product Thumbnail Image

Strategy At Novartis: Culture Change As The 'How' Behind The 'What'

  • Newsletter
  • May 2026
  • 6 Pages
  • Global
From
GSK And Pfizer Start Consumer JV For Different Reasons, Aim For Similar Goals - Product Thumbnail Image

GSK And Pfizer Start Consumer JV For Different Reasons, Aim For Similar Goals

  • Newsletter
  • May 2026
  • 4 Pages
  • Global
From
Schleifer, Yancopoulos And The $36 Billion Friendship - Product Thumbnail Image

Schleifer, Yancopoulos And The $36 Billion Friendship

  • Newsletter
  • May 2026
  • 4 Pages
  • Global
From
Investigator Horror Stories 3: Boozing On The Job? Yup, That Happened - As Have These Other Shocking Tales Of Irregular FDA Inspections - Product Thumbnail Image

Investigator Horror Stories 3: Boozing On The Job? Yup, That Happened - As Have These Other Shocking Tales Of Irregular FDA Inspections

  • Newsletter
  • May 2026
  • 5 Pages
  • Global
From
EMA To Re-Prioritize Tasks To Cope With 'Higher Than Expected' Staff Losses - Product Thumbnail Image

EMA To Re-Prioritize Tasks To Cope With 'Higher Than Expected' Staff Losses

  • Newsletter
  • May 2026
  • 3 Pages
  • Global
From
US FDA May Largely Avoid House Democrats' Investigation Agenda - Product Thumbnail Image

US FDA May Largely Avoid House Democrats' Investigation Agenda

  • Newsletter
  • May 2026
  • 3 Pages
  • United States
From
J&J Scores Early In 'Hypoallergenic' Case; Plaintiff's Definition 'Implausible,' Court Says - Product Thumbnail Image

J&J Scores Early In 'Hypoallergenic' Case; Plaintiff's Definition 'Implausible,' Court Says

  • Newsletter
  • May 2026
  • 3 Pages
  • Global
From
Bayer's US Playbook: The Smart Way To Top-Line Growth - Product Thumbnail Image

Bayer's US Playbook: The Smart Way To Top-Line Growth

  • Newsletter
  • May 2026
  • 7 Pages
  • United States
From
Novartis Pruned Pipeline Producing Attractive Respiratory And Neurology Fruits - Product Thumbnail Image

Novartis Pruned Pipeline Producing Attractive Respiratory And Neurology Fruits

  • Newsletter
  • May 2026
  • 6 Pages
  • Global
From
Swiss Regulatory Change Takes Over 500 OTCs Out Of Pharmacy - Product Thumbnail Image

Swiss Regulatory Change Takes Over 500 OTCs Out Of Pharmacy

  • Newsletter
  • May 2026
  • 3 Pages
  • Switzerland
From
New Year Present For Takeda As Shire Close Nears? - Product Thumbnail Image

New Year Present For Takeda As Shire Close Nears?

  • Newsletter
  • May 2026
  • 4 Pages
  • Global
From
FDA Asks Whether Supplement Industry Has Outgrown Regulatory Framework - Product Thumbnail Image

FDA Asks Whether Supplement Industry Has Outgrown Regulatory Framework

  • Newsletter
  • May 2026
  • 3 Pages
  • Global
From
Merck Steps Out Of Insulin Glargine Market, But Says It Remains Committed To Biosimilars - Product Thumbnail Image

Merck Steps Out Of Insulin Glargine Market, But Says It Remains Committed To Biosimilars

  • Newsletter
  • May 2026
  • 3 Pages
  • Global
From
Biosimilar Suffixes Appear Superfluous In Adverse Event Reporting - Product Thumbnail Image

Biosimilar Suffixes Appear Superfluous In Adverse Event Reporting

  • Newsletter
  • May 2026
  • 4 Pages
  • Global
From
Gilead Lures Roche Pharma CEO O'Day As CEO; Genentech's CEO Will Replace Him - Product Thumbnail Image

Gilead Lures Roche Pharma CEO O'Day As CEO; Genentech's CEO Will Replace Him

  • Newsletter
  • May 2026
  • 3 Pages
  • Global
From
Father of Humira, Greg Winter, Wins 2018 Nobel Prize For Chemistry - Product Thumbnail Image

Father of Humira, Greg Winter, Wins 2018 Nobel Prize For Chemistry

  • Newsletter
  • May 2026
  • 2 Pages
  • Global
From
Gottlieb Uses ASCO Platform To Unveil Two Pilot Programs To Speed Drug Review - Product Thumbnail Image

Gottlieb Uses ASCO Platform To Unveil Two Pilot Programs To Speed Drug Review

  • Newsletter
  • May 2026
  • 4 Pages
  • Global
From
Takeda To Press On With Core R&D Strategy Post-Shire - Product Thumbnail Image

Takeda To Press On With Core R&D Strategy Post-Shire

  • Newsletter
  • May 2026
  • 3 Pages
  • Global
From
AbbVie Hit Harder By EU Humira Biosimilars Than Projected - Product Thumbnail Image

AbbVie Hit Harder By EU Humira Biosimilars Than Projected

  • Newsletter
  • May 2026
  • 3 Pages
  • Europe
From
Bayer's Consumer Chief Initiates Turnaround Plan In Bid To Return Troubled Business To Growth - Product Thumbnail Image

Bayer's Consumer Chief Initiates Turnaround Plan In Bid To Return Troubled Business To Growth

  • Newsletter
  • May 2026
  • 4 Pages
  • Global
From
Loading Indicator